Articles From: Genesee & Wyoming Reports Traffic for July 2014 to Genocea Biosciences, Inc. Elects Not to Pursue Public Offering


Genesee & Wyoming Inc. (G&W) (NYSE:GWR) today reported traffic volumes for July 2014.
Sign-up for Genesee & Wyoming Reports Traffic for July 2014 investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) today reported traffic volumes for June 2014 and the second quarter of 2014.
Sign-up for Genesee & Wyoming Reports Traffic for June 2014 and the Second Quarter of 2014 investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) Chief Financial Officer T.J. Gallagher will present at the Citi Industrials Conference in Boston on Tuesday, Sept.
Sign-up for Genesee & Wyoming to Present at Citi Industrials Conference investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) Chief Financial Officer T.J. Gallagher will present at the Cowen and Company 7th Annual Global Transportation & Aerospace/Defense Conference in Boston on Wednesday, September 3, 2014, at 1:10 p.m. EDT.
Sign-up for Genesee & Wyoming to Present at Cowen and Company 7th Annual Global Transportation & Aerospace/Defense Conference investment picks
Genesee & Wyoming Inc. (G&W) (NYSE:GWR) Chief Financial Officer T.J. Gallagher will present at the RBC Capital Markets Global Industrials Conference in Las Vegas on Tuesday, Sept.
Sign-up for Genesee & Wyoming to Present at RBC Capital Markets Global Industrials Conference investment picks
Genesis Energy, L.P. (NYSE: GEL) today announced the commencement of a registered underwritten public offering of 4,000,000 common units representing limited partner interests.
Sign-up for Genesis Energy, L.P. Announces Public Offering of Common Units investment picks
Genesis Energy, L.P. (NYSE: GEL) announced today that it will pay a regular quarterly distribution of $0.58 per Common Unit for the quarter ended September 30, 2014.
Sign-up for Genesis Energy, L.P. Increases Quarterly Distribution investment picks
Genesis Energy, L.P. (NYSE:GEL) today announced the pricing of a registered underwritten public offering of 4,000,000 common units representing limited partner interests at $50.71 per common unit.
Sign-up for Genesis Energy, L.P. Prices Public Offering of Common Units investment picks
Genesis Energy, L.P. (NYSE:GEL) today announced its second quarter results.
Sign-up for Genesis Energy, L.P. Reports Second Quarter 2014 Results investment picks
Genesis Energy, L.P. (NYSE:GEL) will announce its earnings for the second quarter ended June 30, 2014, before the market opens on Thursday, July 31, 2014.
Sign-up for Genesis Energy, L.P. Sets Date for Release of Second Quarter Results and Conference Call investment picks
Genesis Energy, L.P. (NYSE:GEL) announced today that Grant E.
Sign-up for Genesis Energy, L.P. to Participate in Citigroup MLP/Midstream Infrastructure Conference investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146869&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Genetic Technologies Announces Appointment of Independent Non-Executive Directors investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1146154&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Genetic Technologies Announces Divestment of Australian Based Heritage Business investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1140136&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Genetic Technologies Announces Further Patent Success in USA investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1149344&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Genetic Technologies Announces Quarterly BREVAGen(TM) Results investment picks
http://media.marketwire.com/attachments/201112/37556_Genetic_Technologies_logo95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148431&ProfileId=051205&sourceType=1 MELBOURNE, AUSTRALIA --
Sign-up for Genetic Technologies Launches BREVAGenplus(R) Breast Cancer Risk Assessment Test investment picks
Genie Energy Ltd., (NYSE:GNE), a developer of unconventional energy projects and a leading independent retail energy provider, participated in EnerCom’s The Oil and Gas Conference in Denver, CO on August 21 st .
Sign-up for Genie Energy (GNE) at EnerCom’s 2014 The Oil and Gas Conference investment picks
Genie Energy Ltd., (NYSE: GNE), a developer of unconventional energy projects and a leading independent retail energy provider, will present at the Liolios Group’s Third Annual Gateway Conference on September 4, 2014 in San Francisco.
Sign-up for Genie Energy (GNE) to Present at 2014 Gateway Conference investment picks
Genie Energy Ltd., (NYSE:GNE) a leading independent retail energy provider and a developer of unconventional energy projects, will announce financial results for the second quarter of 2014 on Thursday, August 7, 2014.
Sign-up for Genie Energy (GNE) to Report Second Quarter 2014 Results investment picks
Genie Energy Ltd., (NYSE:GNE) a leading independent retail energy provider and a developer of unconventional energy projects, said today that on September 2, 2014, the Jerusalem District Committee for Planning and Building voted to decline to issue Israel Energy Initiatives, Ltd.
Sign-up for Genie Energy Considering Alternative Ways Forward for Oil Shale Pilot Project in Israel investment picks
Genie Energy Ltd.
Sign-up for Genie Energy Signs Agreement for Additional Oil Shale Exploration in Mongolia investment picks
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced positive preliminary second quarter 2014 results and an update on its NexGen system.
Sign-up for GenMark Announces Positive Preliminary Second Quarter Results investment picks
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced the appointment of Dr.
Sign-up for GenMark Diagnostics Appoints Dr. James Fox as Chairman of the Board investment picks
GenMark Diagnostics, Inc. (Nasdaq:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported financial results for the quarter ended June 30, 2014.
Sign-up for GenMark Diagnostics Reports Second Quarter 2014 Results investment picks
GenMark Diagnostics, Inc. (NASDAQ:GNMK) today announced that it plans to release its second quarter earnings results after market close on Monday, August 11, 2014.
Sign-up for GenMark Diagnostics Schedules Second Quarter 2014 Financial Results Conference Call for August 11, 2014 investment picks
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, will present at the Canaccord Genuity 34th Annual Growth Conference to be held at the InterContinental Boston Hotel in Boston, MA on Wednesday, August 13, 2014.
Sign-up for GenMark Diagnostics to Present at the Canaccord Genuity 34th Annual Growth Conference investment picks
Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced the receipt of a $1.2 million grant from the Bill & Melinda Gates Foundation for the identification of protective T cell antigens for malaria vaccines.
Sign-up for Genocea Announces $1.2 Million Grant for Malaria Vaccine Discovery investment picks
Genocea Biosciences, Inc. (NASDAQ: GNCA), a clinical-stage biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Kenneth Bate has joined the company’s board of directors.
Sign-up for Genocea Appoints Kenneth Bate to its Board of Directors investment picks
Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today announced that it has commenced an underwritten public offering of 3,400,000 shares of its common stock.
Sign-up for Genocea Biosciences, Inc. Commences Public Offering of Common Stock investment picks
Genocea Biosciences, Inc. (NASDAQ:GNCA), a clinical-stage biopharmaceutical company developing T cell-enabled vaccines and immunotherapies, today announced that, due to market conditions, it has elected not to proceed at this time with its previously announced plans to pursue an underwritten public offering of 3,400,000 shares of its common stock.
Sign-up for Genocea Biosciences, Inc. Elects Not to Pursue Public Offering investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Genesee & Wyoming Reports Traffic for July 2014 to Genocea Biosciences, Inc. Elects Not to Pursue Public Offering
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices